Investigating socioeconomic disparities in prescribing new diabetes medications in individuals with type 2 diabetes and very high cardiovascular risk in the Netherlands
Primary Care Diabetes · 2025
DOI: 10.1016/j.pcd.2024.12.011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Primary Care Diabetes, 2025. Verfasst von Frank H Ardesch und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health and Primary Care/Health Campus The Hague, Leiden University Medical Center, the Netherlands. Electronic address: F.H.Arde…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Healthcare Disparities, Cardiovascular Diseases, Practice Patterns, Physicians'. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
AIMS: This study aims to analyze prescription patterns of new diabetes medication and assess socioeconomic disparities in their initiation among individuals with T2DM with very high cardiovascular risk. METHODS: Individuals diagnosed with T2DM and very high cardiovascular risk were identified (N = 10,768) based on general practitioner's electronic health record data. SGLT-2is and GLP-1RAs prescription patterns were examined. Furthermore, the association between SES and the prescription of SGLT-2is and GLP-1RAs in 2022 was investigated. RESULTS: Despite the increase in prescription rates of SGLT-2is and GLP-1RAs between 2019 and 2022, approximately 85 % and 93 % of eligible individuals did not receive SGLT-2is and GLP-1RAs in 2022, respectively. We found a positive association between SGLT-2is prescription and SES in only the 4th quintile compared to 1st quintile (referent) in the fully adjusted model (OR 1.29 95 % CI:1.08-1.54). CONCLUSIONS: The prescription rates among eligible individuals highlight significant room for improvement in aligning prescribing practices with guidelines. We found no profound socioeconomic gradient in initiation of SGLT-2is and GLP-1RAs. The latter may be due to guidelines' clear indication of the eligible population and GP education. Future development and potential disparities in initiation and maintenance should be monitored to ensure equitable prescribing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Public Health and Primary Care/Health Campus The Hague, Leiden University Medical Center, the Netherlands. Electronic address: F.H.Ardesch@lumc.nl.
- Department of Health Services Research, CAPHRI Care and Public Health Research Institute, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands. Electronic address: R.Geurten@…
- Department of Public Health and Primary Care/Health Campus The Hague, Leiden University Medical Center, the Netherlands; Department of Population Health and Health Services Research, National Institute of Public Health…
- Department of Health Services Research, CAPHRI Care and Public Health Research Institute, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands. Electronic address: D.Ruwaard@…
- Department of Internal Medicine, University of Groningen and University Medical Center Groningen, Groningen, the Netherlands. Electronic address: H.J.G.Bilo@isala.nl.
- Department of Health Services Research, CAPHRI Care and Public Health Research Institute, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands. Electronic address: A.Elissen@…
Zitieren
APA
Ardesch, F. H., Geurten, R. J., Struijs, J. N., Ruwaard, D., Bilo, H. J. G., & Elissen, A. M. J. (2025). Investigating socioeconomic disparities in prescribing new diabetes medications in individuals with type 2 diabetes and very high cardiovascular risk in the Netherlands. Primary Care Diabetes. https://doi.org/10.1016/j.pcd.2024.12.011
Vancouver
Ardesch FH, Geurten RJ, Struijs JN, Ruwaard D, Bilo HJG, Elissen AMJ. Investigating socioeconomic disparities in prescribing new diabetes medications in individuals with type 2 diabetes and very high cardiovascular risk in the Netherlands. Primary Care Diabetes. 2025. doi:10.1016/j.pcd.2024.12.011
BibTeX
@article{Ardesch2025,
author = {Ardesch, Frank H and Geurten, Rose J and Struijs, Jeroen N and Ruwaard, Dirk and Bilo, Henk J G and Elissen, Arianne M J},
title = {Investigating socioeconomic disparities in prescribing new diabetes medications in individuals with type 2 diabetes and very high cardiovascular risk in the Netherlands},
journal = {Primary Care Diabetes},
year = {2025},
doi = {10.1016/j.pcd.2024.12.011}
}
EUVIMED